Hashimoto M - Search Results

1

SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.

Naito M, Matsui A, Inao M, Nagoshi S, Nagano M, Ito N, Egashira T, Hashimoto M, Mishiro S, Mochida S, Fujiwara K. Naito M, et al. Among authors: hashimoto m. J Gastroenterol. 2005 Apr;40(4):381-8. doi: 10.1007/s00535-005-1558-3. J Gastroenterol. 2005. PMID: 15868370

2

Genetic polymorphims in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients.

Mochida S, Hashimoto M, Matsui A, Naito M, Inao M, Nagoshi S, Nagano M, Egashira T, Mishiro S, Fujiwara K. Mochida S, et al. Among authors: hashimoto m. Biochem Biophys Res Commun. 2004 Jan 23;313(4):1079-85. doi: 10.1016/j.bbrc.2003.12.045. Biochem Biophys Res Commun. 2004. PMID: 14706653

3

Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro.

Hijikata M, Mishiro S, Miyamoto C, Furuichi Y, Hashimoto M, Ohta Y. Hijikata M, et al. Among authors: hashimoto m. Intervirology. 2001;44(6):379-82. doi: 10.1159/000050075. Intervirology. 2001. PMID: 11805446

4

The dinucleotide microsatellite polymorphism of the IFNAR1 gene promoter correlates with responsiveness of hepatitis C patients to interferon.

Matsuyama N, Mishiro S, Sugimoto M, Furuichi Y, Hashimoto M, Hijikata M, Ohta Y. Matsuyama N, et al. Among authors: hashimoto m. Hepatol Res. 2003 Mar;25(3):221-225. doi: 10.1016/s1386-6346(02)00269-3. Hepatol Res. 2003. PMID: 12697242

5

Electrochemical DNA array for simultaneous genotyping of single-nucleotide polymorphisms associated with the therapeutic effect of interferon.

Takahashi M, Okada J, Ito K, Hashimoto M, Hashimoto K, Yoshida Y, Furuichi Y, Ohta Y, Mishiro S, Gemma N. Takahashi M, et al. Among authors: hashimoto m, hashimoto k. Clin Chem. 2004 Mar;50(3):658-61. doi: 10.1373/clinchem.2003.023283. Clin Chem. 2004. PMID: 14981038 No abstract available.

6

Construction of an electrochemical DNA chip for simultaneous genotyping of single nucleotide polymorphisms.

Takahashi M, Okada J, Ito K, Hashimoto M, Hashimoto K, Yoshida Y, Furuichi Y, Ohta Y, Mishiro S, Gemma N. Takahashi M, et al. Among authors: hashimoto m, hashimoto k. Analyst. 2005 May;130(5):687-93. doi: 10.1039/b414030n. Epub 2005 Mar 22. Analyst. 2005. PMID: 15852138

7

Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study.

Okazaki A, Matsuda S, Kotani T, Fukui K, Gon T, Watanabe R, Manabe A, Shoji M, Kadoba K, Hiwa R, Yamamoto W, Hashimoto M, Takeuchi T. Okazaki A, et al. Among authors: hashimoto m. Front Immunol. 2025 Jan 20;15:1450153. doi: 10.3389/fimmu.2024.1450153. eCollection 2024. Front Immunol. 2025. PMID: 39902054 Free PMC article.

8

Gender differences in pharmacy professors in Japan and Korea.

Maeda H, Soh H, Hashimoto M, Han E, Ohno E. Maeda H, et al. Among authors: hashimoto m. Lancet Reg Health West Pac. 2025 Jan 15;54:101469. doi: 10.1016/j.lanwpc.2025.101469. eCollection 2025 Jan. Lancet Reg Health West Pac. 2025. PMID: 39896898 Free PMC article. No abstract available.

9

Association of body mass index and tumor response in metastatic urothelial carcinoma treated with enfortumab vedotin: data from the ULTRA-Japan consortium.

Uchimoto T, Iwatsuki K, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Hashimoto M, Minami T, Yamamoto Y, Yamazaki S, Takai T, Sakamoto M, Nakajima Y, Nishimura K, Maenosono R, Tsujino T, Nakamura K, Fukushima T, Nishio K, Yoshikawa Y, Yamamoto S, Iwatani K, Urabe F, Mori K, Yanagisawa T, Tsuduki S, Takahara K, Fujita K, Kimura T, Ohno Y, Shiroki R, Azuma H. Uchimoto T, et al. Among authors: hashimoto m. Int J Clin Oncol. 2025 Jan 31. doi: 10.1007/s10147-025-02709-1. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39890750

10

Validation of the Japanese version of the Social Functioning in Dementia scale and COVID-19 pandemic's impact on social function in mild cognitive impairment and mild dementia.

Umeda S, Kanemoto H, Suzuki M, Wada T, Suehiro T, Kakeda K, Nakatani Y, Satake Y, Yamakawa M, Koizumi F, Taomoto D, Hikida S, Hirakawa N, Sommerlad A, Livingston G, Hashimoto M, Yoshiyama K, Ikeda M. Umeda S, et al. Among authors: hashimoto m. Int Psychogeriatr. 2024 Dec;36(12):1205-1218. doi: 10.1017/S1041610224000401. Int Psychogeriatr. 2024. PMID: 39890399 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,730 results

Search Page

Filters